A matter of dose?;Alles eine frage der dosis?

Allergo Journal

Volumn 14, Issue SUPPL. 1, 2005, Pages

  Merk, F Hans ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; MEDICAL PROFESSION; T LYMPHOCYTE;

EID: 25444436494     PISSN: 09418849     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03371919     Document Type: Editorial

References (20)

1. André C. The development of local immunotherapy. Recent Res Devel Allergy Clin Immunol 2001; 2: 45-53
2. Bousquet J, van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108: S147-334
3. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. Allergy 1998; 53 Suppl 44: 1-42
4. Calderon M, Rak S, Durham SR. Grass pollen tablets for sublingual immunotherapy in seasonal allergic rhinitis. J Allergy Clinical Immunol, 2005; 115: S65.
5. Kägi MK, Wüthrich B. Different methods of local allergen-specific immunotherapy. Allergy 2002; 57: 379-88
6. Khinchi MS, Poulsen LK, Carat F, André C, Hansen AB, Malling HJ. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004; 59: 45-53
7. Kleine-Tebbe J, Bergmann K-C, Bufe A, Friedrichs F, Fuchs T, Hirsch T, Klimek L, Lepp U, Przybilla B, Rakoski J, Rebien W, Saloga J, Schultze-Werninghaus G, Virchow J-C. Aktueller Stellenwert der sublingualen Immuntherapie bei allergischen Krankheiten. Allergologie 2004; 27: 381-84
8. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 1987; 79: 660-77
9. Lüderitz-Püchel U, Keller-Stanislawski B, Haustein D. Neubewertung des Risikos von Test- und Therapieallergenen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2001; 44: 709-18
10. Maetzke J, Hinrichs R, Scharffetter-Kochanek K. Notwendigkeit der standardisierten Qualität der sublingualen Immuntherapie. Allergo J 2005; 14: 253-4
11. n. Mailing HJ. Immunotherapy as an effective tool in allergy treatment. Allergy 1998; 53: 461-72
12. Mailing HJ. Is sublingual immunotherapy clinically effective? Curr Opin Allergy Clin Immunol 2002; 2: 523-31
13. Marcucci F, Sensi L, Di Cara G, Incorvaia C, Frati F. Dose dependence of immunological response to sublingual immunotherapy. Allergy 2005; 60: 952-6
14. Martin-Fontecha A, Sebastiani S, Hopken UE, Uguccioni M, Lipp M, Lanzavecchia A, Sallusto F. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 2003; 198: 615-21
15. Noirey N, Rougier N, André C, Schmitt D, Vincent C. Langerhans-like dendritic cells generated from cord blood progenitors internalize pollen allergens by macropinocytosis, and part of the molecules are processed and can activate autologous naive T lymphocytes. J Allergy Clin Immunol 2000; 105: 1194-201
16. Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De Marco E, Burastero SE, Calori G, Benetti L, Bonazza P, Puccinelli P, Parmiani S, Bernardini R, Vierucci A. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004; 114: 851-7
17. Reid MJ, Lockey RF, Turkeltaub PC, Platts-Mills TA. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 1993; 92: 6-15
18. Di Rienzo V, Marcucci F, Puccinelli P, Parmiani S, Frati F, Sensi L, Canonica GW, Passalacqua G. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003; 33: 206-10
19. Wilson DR, Torres Lima M, Durham SR. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2003: CD002893
20. Wilson DR, Torres Lima M, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005; 60: 4-12